Millendo Therapeutics Inc.

(MLND) Trade

By |

Profile

Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS).

Contact Information

Website: www.millendo.com
Email: ir@ovascience.com
Main Phone: +1 734 845-9000
Address: 301 North Main Street
Address 2: Suite 100
State: MI
City / Town: Ann Arbor
Country: USA
Postal Code: 48104

Issuer Information

Exchange: NSC
CEO: Julia C. Owens
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)


Gathering Data... Please wait

Profile

Millendo Therapeutics Inc is a late-stage biopharmaceutical company focused on developing novel treatments for orphan endocrine diseases. Its lead asset, livoletide, is an unacylated ghrelin analogue being developed for the treatment of Prader-Willi syndrome (PWS), a rare genetic disease characterized by hyperphagia, a chronic unrelenting hunger, that leads to obesity, metabolic dysfunction, reduced quality of life and early mortality. The company is also developing nevanimibe, an ACAT1 inhibitor for the treatment of two orphan adrenal diseases: classic congenital adrenal hyperplasia (CAH) and endogenous Cushing's syndrome (CS).

Contact Information

Website: www.millendo.com
Email: ir@ovascience.com
Main Phone: +1 734 845-9000
Address: 301 North Main Street
Address 2: Suite 100
State: MI
City / Town: Ann Arbor
Country: USA
Postal Code: 48104

Issuer Information

Exchange: NSC
CEO: Julia C. Owens
Employees: 37
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 6.98 $ 0. (0.00%)
Last Price 6.98 Change $ 0. Change % 0.00 Tick N/A
Bid 6.80 Bid Size 100.00 Ask 6.90 Ask Size 300.00
Open N/A High N/A Low N/A Prev Close 6.98
Last Trade Volume 139 52 Wk Hi 17.34 52 Wk Low 6.64
Market Cap 93.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 13,412,058.00 EPS (TTM) -12.80 PE Ratio N/A Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 3 12
Number of Buys 3 12
Number of Sells 0 0
Net Activity 37423 120707
Last 10 Buys Shares
Richard H. Aldrich 1,000
Michelle Dipp 1,000
Michelle Dipp 1,000
Richard H. Aldrich 1,000
Michelle Dipp 1,000
Michelle Dipp 1,000
Richard H. Aldrich 1,000
Michelle Dipp 1,000
Richard H. Aldrich 1,000
Richard H. Aldrich 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 15 15 15 15
Low Target Price Estimate 15 15 15 15
Mean Target Price Estimate 15 15 15 15
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 11/06/17 11/06/17 11/06/17 11/06/17
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1